The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 3:15 AM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #3. ICON Aptiv Solutions

Acquirer: ICON (NASDAQ:ICLR)
Acquiree: Aptiv Solutions
Details: ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the previously announced acquisition of Aptiv Solutions.

Icon is a clinical research organization. Co. operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. Co. provides a range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. engages in the development, management and analysis of programs that support various stages of the clinical development process. Co. provides services including clinical trial management, consulting, contract staffing and laboratory services.

Open the ICLR Page at The Online Investor »

Company Name: 
Icon Plc
Stock buyback: 
ICLR buyback
Website: 
www.iconplc.com
Sector: 
Biotechnology
Number of ETFs Holding ICLR: 
5
Total Market Value Held by ETFs: 
$9.46M
Total Market Capitalization: 
$10.83B
% of Market Cap. Held by ETFs: 
0.09%
 

Open the ICLR Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.09 out of 4)
34th percentile
(ranked lower than approx. 66% of all stocks covered)

Analysts' Target Price:
ICLR Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 3 of 83 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.